Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2013 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Provides PROCYSBI(TM) Launch Update and Second Quarter 2013 Financial Results

NOVATO, Calif., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today provided a launch update for PROCYSBI (cysteamine bitartrate) delayed-release capsules and financial...
August 06, 2013 07:29 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at Upcoming Investor Conference

NOVATO, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Julie Anne Smith, Raptor's Executive Vice President, Strategy and Chief Operating...
August 01, 2013 07:29 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 8, 2013

NOVATO, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2013 financial results after market close on Thursday,...
July 22, 2013 07:00 ET | Source: Raptor Pharmaceutical Inc

PROCYSBI(R) Receives Positive Opinion for Orphan Drug Exclusivity From the EU Committee for Orphan Medicinal Products

NOVATO, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has received a positive opinion from the European Union (EU) Committee for Orphan...
July 02, 2013 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at Upcoming Investor Conference

NOVATO, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Christopher M. Starr, Ph.D., Raptor's CEO, will present an overview of the company at...
June 28, 2013 08:34 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical's PROCYSBI(TM) Receives Positive Recommendation From CHMP

NOVATO, Calif., June 28, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced today that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a...
June 25, 2013 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor's PROCYSBI(TM) Receives U.S. Orphan Drug Exclusivity

NOVATO, Calif., June 25, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Office of Orphan Product Development at the Food and Drug Administration (FDA)...
June 19, 2013 07:00 ET | Source: Raptor Pharmaceutical Inc

Raptor's PROCYSBI(TM) Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients

NOVATO, Calif., June 19, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that PROCYSBI™ (cysteamine bitartrate) delayed-release capsules are now available in...
June 12, 2013 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at Upcoming Investor Conference

NOVATO, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Julie Anne Smith, executive vice president, strategy and chief operating officer of...
May 08, 2013 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results

NOVATO, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq:RPTP) today reported financial results for its first quarter ended March 31,...